Cobra Biologics

Cobra Biologics, together with its parent company Cognate BioServices, is a leading international contract development and manufacturing organization (CDMO) providing the highest quality development and manufacturing services for the cell and gene therapy fields, ranging from early stage development and pre-clinical services to clinical commercial supply.

Cobra and Cognate service an international customer base from its manufacturing and development facilities in the UK, Sweden, and the US. Each of the Company's GMP approved facilities are tailored to serve our customers
around the world. We offer a broad range of integrated and stand-alone contract development and manufacturing services for the clinical trial and the commercial markets.

As a trusted provider and a key partner in the drug development and commercialization process, we take pride in our manufacturing excellence and comprehensive range ofservices to the pharmaceutical and biotech industries.

Visit our website for more information and to request a call back www.cobrabio.com